76 related articles for article (PubMed ID: 3453959)
1. Roentgen rounds #86. Metastatic Hürthle cell carcinoma.
Rames R; Kriegshauser L; Gilula LA
Orthop Rev; 1987 Jan; 16(1):60-3. PubMed ID: 3453959
[No Abstract] [Full Text] [Related]
2. Radionuclide treatment of metastatic disease in patients with differentiated thyroid carcinoma.
Mihailović J; Trifunović J
Vojnosanit Pregl; 2012 Oct; 69(10):899-903. PubMed ID: 23155612
[No Abstract] [Full Text] [Related]
3. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients.
Samaan NA; Schultz PN; Haynie TP; Ordonez NG
J Clin Endocrinol Metab; 1985 Feb; 60(2):376-80. PubMed ID: 3965495
[TBL] [Abstract][Full Text] [Related]
4. Cerebral edema following iodine-131 therapy for thyroid carcinoma metastatic to the brain.
Datz FL
J Nucl Med; 1986 May; 27(5):637-40. PubMed ID: 3712081
[TBL] [Abstract][Full Text] [Related]
5. [Dynamics of the x-ray picture of bone metastases of thyroid cancer as affected by radiotherapy].
Kiseleva ES; Zvekotkina LS; Babushkin VV
Med Radiol (Mosk); 1989 Mar; 34(3):6-10. PubMed ID: 2927278
[TBL] [Abstract][Full Text] [Related]
6. [Metabolic therapy with radioiodine of differentiated thyroid tumor].
Bestagno M; Campagnari G
Minerva Med; 1986 Nov; 77(44):2113-6. PubMed ID: 3785727
[No Abstract] [Full Text] [Related]
7. Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans.
Sabra MM; Grewal RK; Tala H; Larson SM; Tuttle RM
Thyroid; 2012 Sep; 22(9):877-83. PubMed ID: 22827641
[TBL] [Abstract][Full Text] [Related]
8. [Long-term results of iodine radioisotope therapy for lung metastasis of thyroid cancer].
Tsyb AF; Drozdovskiĭ BI; Proshin VV
Vopr Onkol; 1996; 42(3):73-5. PubMed ID: 8801748
[TBL] [Abstract][Full Text] [Related]
9. Renal metastases from thyroid carcinoma.
Malhotra G; Asopa R; Rajan MG
Thyroid; 2010 Nov; 20(11):1321; author reply 321-2. PubMed ID: 21062198
[No Abstract] [Full Text] [Related]
10. Metastatic bone neoplasms.
Strübbe EH; Rosencrantz NM
J Belge Radiol; 1993 Dec; 76(6):408. PubMed ID: 8163451
[No Abstract] [Full Text] [Related]
11. 131I dosimetry and thyroid stunning.
Gerard SK; Park HM
J Nucl Med; 2003 Dec; 44(12):2039-40; author reply 2040. PubMed ID: 14660731
[No Abstract] [Full Text] [Related]
12. Metastatic anaplastic thyroid carcinoma to the right ventricle of the heart.
Haggerty MF; Murphy TM
AJR Am J Roentgenol; 1990 Nov; 155(5):1136. PubMed ID: 2120951
[No Abstract] [Full Text] [Related]
13. Role of radioiodine in management of thyroid cancer: experience with 70 cases.
Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L
Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083
[TBL] [Abstract][Full Text] [Related]
14. Malignant transformation of a Hürthle cell tumor: case report and survey of the literature.
McDonald RJ; Wu SY; Jensen JL; Parker LN; Lyons KP; Moran EM; Blahd WH
J Nucl Med; 1991 Jun; 32(6):1266-9. PubMed ID: 2045945
[TBL] [Abstract][Full Text] [Related]
15. Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma.
Van Nostrand D; Atkins F; Yeganeh F; Acio E; Bursaw R; Wartofsky L
Thyroid; 2002 Feb; 12(2):121-34. PubMed ID: 11916281
[TBL] [Abstract][Full Text] [Related]
16. The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
Robbins RJ; Schlumberger MJ
J Nucl Med; 2005 Jan; 46 Suppl 1():28S-37S. PubMed ID: 15653649
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
18. Hürthle cell neoplasms of the thyroid gland: reassessment of functional capacity.
Caplan RH; Abellera RM; Kisken WA
Thyroid; 1994; 4(3):243-8. PubMed ID: 7833658
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid.
Balon HR; Fink-BennetT D; Stoffer SS
J Nucl Med; 1992 Jul; 33(7):1393-5. PubMed ID: 1535374
[TBL] [Abstract][Full Text] [Related]
20. Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma.
Koong SS; Reynolds JC; Movius EG; Keenan AM; Ain KB; Lakshmanan MC; Robbins J
J Clin Endocrinol Metab; 1999 Mar; 84(3):912-6. PubMed ID: 10084570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
